Showing results (1-10 of 332) with videos related to

Sort By:
Pageof 34
Expert Review of Clinical Pharmacology|November 26, 2011
Potential mechanisms of efficacy and adverse effects in the use of fingolimod (FTY720)Daniel Ontaneda, Jeffrey A Cohen
Annual Review of Medicine|September 6, 2011
Multiple sclerosis: new insights in pathogenesis and novel therapeuticsDaniel Ontaneda, Megan Hyland, Jeffrey A Cohen
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical outcome measures for progressive MS trialsDaniel Ontaneda, Jeffrey A Cohen, Maria Pia Amato
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2019
Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in uteroAndrew L Smith, Jeffrey A Cohen, Daniel Ontaneda, et al.
Lancet (London, England)|November 28, 2016
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of functionDaniel Ontaneda, Alan J Thompson, Robert J Fox, et al.
Cleveland Clinic Journal of Medicine|April 3, 2023
Reproductive issues and multiple sclerosis: 20 questionsAlise K Carlson, Daniel Ontaneda, Mary R Rensel, et al.
Annals of Neurology|April 15, 2020
Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple SclerosisKedar R Mahajan, Kunio Nakamura, Jeffrey A Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 29, 2024
Ibudilast reduces slowly enlarging lesions in progressive multiple sclerosisKunio Nakamura, Bhaskar Thoomukuntla, James Bena, et al.
Journal of the Neurological Sciences|October 9, 2012
Early tolerability and safety of fingolimod in clinical practiceDaniel Ontaneda, Claire Hara-Cleaver, Richard A Rudick, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2023
Effect of ibudilast on thalamic magnetization transfer ratio and volume in progressive multiple sclerosisKunio Nakamura, Yufan Zheng, Kedar R Mahajan, et al.
Pageof 34